Delivery Order SPE2DE24D0013-SPE2D626F602K
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, has been awarded a delivery order valued at $16,381 by the Defense Logistics Agency Medical Supply Chain for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic supplies. The delivery order, issued on November 12, 2025, with an ultimate completion date of November 19, 2025, utilizes a firm fixed-price structure with no set-aside designation. This award represents a continuation of...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, received a $4,198.65 firm fixed-price delivery order (Contract No. 4569971781) from the Defense Logistics Agency Medical Supply Chain on November 10, 2025, for respiratory pathogen diagnostic supplies related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The delivery order is scheduled for completion by November 18, 2025, and carries no set-aside designation. The award...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order valued at $40,800 by the Defense Logistics Agency Medical Supply Chain on December 8, 2025, for diagnostic supplies supporting COVID-19, influenza, and respiratory syncytial virus (RSV) testing capabilities. The delivery order, designated XPCOV2/FLU/RSV-10, carries a firm fixed-price structure with an ultimate completion date of December 15, 2025, and is...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order valued at $5,236.00 by the Defense Logistics Agency Medical Supply Chain on October 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing supplies supporting detection of COVID-19, influenza, and respiratory syncytial virus, with a firm fixed-price structure and ultimate completion date of November 10, 2025. The contract...
- Cepheid Inc. has been awarded a delivery order valued at $13,096.80 by the Defense Logistics Agency Medical Supply Chain for diagnostic testing supplies and reagents related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The delivery order, designated XPCOV2/FLU/RSV-10, carries a firm fixed-price structure with an ultimate completion date of December 2, 2025, and will be performed at Cepheid's headquarters in Sunnyvale, California. This contract carries no set-aside...
- Cepheid Inc., a molecular diagnostics manufacturer headquartered in Sunnyvale, California, was awarded a delivery order valued at $5,440 on December 5, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, designated as XPCOV2/FLU/RSV-10, is scheduled for completion by December 12, 2025, and will be performed at the contractor's Sunnyvale facility. The award carries no set-aside designation, reflecting Cepheid's competitive positioning in...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $11,987 by the Defense Logistics Agency's Medical Supply Chain on December 11, 2025, with completion scheduled for December 18, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, represents a firm fixed-price procurement with no set-aside designation and utilizes a Firm Fixed Price contract structure. Based on the product designation, this delivery...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $10,914 on September 22, 2025, by the Defense Logistics Agency's Medical Supply Chain division under the Defense Department. The firm fixed-price delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by October 6, 2025, and will be performed at Cepheid's Sunnyvale facility. This award carries no set-aside designation and represents procurement...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 by the Defense Logistics Agency's Medical Supply Chain division on August 22, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by August 29, 2025, and covers molecular diagnostic testing solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $13,600 on December 11, 2025, by the Defense Logistics Agency Medical Supply Chain. The contract, designated 4570254411 and titled XPCOV2/FLU/RSV-10, is structured as a firm fixed-price delivery order with an ultimate completion date of December 18, 2025, and carries no set-aside designation. This delivery order involves the supply of molecular diagnostic...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F602KDelivery Order
Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, received a delivery order valued at $5,440 on December 1, 2025, from the Defense Logistics Agency Medical Supply Chain for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic supplies. This firm fixed-price delivery order, with an ultimate completion date of December 8, 2025, carries no set-aside designation and represents a continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic testing solutions. The Medical Supply Chain, operating under the Department of Defense, procures medical supplies and equipment for defense and military healthcare operations. This modest delivery order reflects Cepheid's position within the Defense Logistics Agency's broader procurement network for diagnostic testing capabilities. The company maintains extensive federal contracts across multiple agencies, including substantial Indefinite Delivery Contracts with the Department of Veterans Affairs valued at tens of millions of dollars through 2030. Cepheid's GeneXpert diagnostic platform and associated test cartridges have become standard equipment across federal healthcare systems, including the VA, Defense Health Agency, Indian Health Service, and U.S. Coast Guard, supporting rapid molecular testing for infectious diseases and clinical conditions. The current order demonstrates ongoing demand for respiratory pathogen testing supplies within the defense healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 11/30/25 |